Literature DB >> 15713855

Vascular parkinsonism--an important cause of parkinsonism in older people.

Bhomraj Thanvi1, Nelson Lo, Tom Robinson.   

Abstract

Parkinsonism due to cerebrovascular disease (vascular parkinsonism, VP) is a distinct clinicopathological entity. It accounts for 4.4-12% of all cases of parkinsonism. Since there are no specific diagnostic criteria, true incidence and prevalence rates of VP are not known. Typically, parkinsonism in slow-onset VP tends to be bilaterally symmetrical, affecting the lower limbs more than the upper limbs ('lower-body parkinsonism'), and resting tremor is usually absent. Commonly noted lesions on brain imaging in VP are lacunes, white matter changes and, rarely, territorial infarcts. As coincidental vascular lesions in idiopathic Parkinson's disease (PD) are common, the mere presence of these lesions on brain imaging is not diagnostic of VP. Pathological evidence of a vascular disease in the absence of typical PD lesions (e.g. Lewy bodies) is the diagnostic 'gold standard'. VP is generally considered to be poorly or non-responsive to L-dopa therapy. However, recent studies have shown a beneficial effect of L-dopa in a subset of patients. Despite great advances in overall understanding of the disease, there are several gaps in our knowledge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713855     DOI: 10.1093/ageing/afi025

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  28 in total

1.  Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system.

Authors:  F Wegner; K Strecker; J Schwarz; A Wagner; W Heinritz; F Sommerer; D R Thal; J-P Schneider; K Kendziorra; O Sabri
Journal:  J Neurol       Date:  2007-11-21       Impact factor: 4.849

2.  Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells.

Authors:  Shaletha Holmes; Babak Abbassi; Chang Su; Meharvan Singh; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2013-08-19       Impact factor: 4.736

Review 3.  Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Authors:  Christian Schenk; Timothy Wuerz; Alan J Lerner
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

4.  Patterns of chronic venous insufficiency in the dural sinuses and extracranial draining veins and their relationship with white matter hyperintensities for patients with Parkinson's disease.

Authors:  Manju Liu; Haibo Xu; Yuhui Wang; Yi Zhong; Shuang Xia; David Utriainen; Tao Wang; E Mark Haacke
Journal:  J Vasc Surg       Date:  2014-03-19       Impact factor: 4.268

Review 5.  Vascular Parkinsonism: deconstructing a syndrome.

Authors:  Joaquin A Vizcarra; Anthony E Lang; Kapil D Sethi; Alberto J Espay
Journal:  Mov Disord       Date:  2015-05-21       Impact factor: 10.338

Review 6.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

7.  Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of "vascular CBS".

Authors:  Shunsuke Koga; Shanu F Roemer; Koji Kasanuki; Dennis W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2019-09-02       Impact factor: 4.891

8.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  A 5-Year Follow-up Study on the Relationship between Obstructive Sleep Apnea and Parkinson Disease.

Authors:  Jau-Jiuan Sheu; Hsin-Chien Lee; Herng-Ching Lin; Li-Ting Kao; Shiu-Dong Chung
Journal:  J Clin Sleep Med       Date:  2015-12-15       Impact factor: 4.062

10.  Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors:  Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2013-01-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.